ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Heart disease"

  • Abstract Number: 2589 • 2013 ACR/ARHP Annual Meeting

    Scleroderma Patients With Pulmonary Hypertension and Increased Pulmonary Capillary Wedge Pressure In The Pulmonary Hypertension Assessment and Recognition Of Outcomes In Scleroderma (PHAROS) Cohort

    Matthew R. Lammi1,2, Lesley Ann Saketkoo3,4, Jessica K. Gordon5, Paula Lauto6 and Virginia D. Steen7, 1Section of Pulmonary and Critical Care Medicine, LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, 2Louisiana State University Health Sciences Center, Pulmonary and Critical Medicine, New Orleans, LA, 3Scleroderma and Sarcoidosis Patient Care and Research Center, Rheumatology and Pulmonary Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, 4LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, 5Rheumatology, Hospital for Special Surgery, New York, NY, 6Pulmonary and Critical Care Medicine, LSU Health Sciences Center, New Orleans, LA, 7Department of Rheumatology, Georgetown University Medical Center, Washington, DC

    Background/Purpose: Systemic sclerosis (SSc) commonly leads to pulmonary hypertension (PH), which may be associated with left heart disease and an elevated pulmonary capillary wedge pressure…
  • Abstract Number: 2038 • 2013 ACR/ARHP Annual Meeting

    Congenital Heart Block Related With Maternal Autoimmune Diseases: Descriptive Analysis Of a Series Of 17 Cases

    Pamela Inés Doti1, Ona Escoda2, Sergi Cesar-Diaz3, Narcís Masoller4, Irene Teixidó4, Josep Maria Martinez4, Georgia Sarquella-Brugada5 and Gerard Espinosa2, 1Department of Autoimmune Diseases, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Barcelona, Spain, 2Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Barcelona, Spain, 3Arrhythmia Unit, Cardiology Section, Arrhythmia Unit, Cardiology Section, Hospital Sant Joan de Déu, Barcelona, Barcelona, Spain, 4Maternal Fetal Medicine Department, Hospital Clínic, Bacelona, Barcelona, Spain, 5Arrhythmia Unit, Cardiology Section, Hospital Sant Joan de Déu, Barcelona, Barcelona, Spain

    Background/Purpose: To describe the clinical characteristics of maternal autoimmune-mediated fetal congenital heart block (CHB) in a cohort of pregnant women from an Autoimmune Diseases Pregnancy…
  • Abstract Number: 1277 • 2013 ACR/ARHP Annual Meeting

    A Pilot Study Of Young Adults With Juvenile Dermatomyositis With Decreased Nailfold Capillary End Row Loops:  Brachial Artery Reactivity and Oxidized Lipids

    Lauren M. Pachman1,2, Maureen A. McMahon3, Tamar Polonsky4, Gabrielle A. Morgan1, Maria Amoruso5 and Chiang-Ching Huang6, 1Cure JM Myositis Center, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL, 2Division of Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Division of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 4Cardiology, University of Chicago Medicine, Chicago, IL, 5Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Cure JM Myositis Center, Chicago, IL, 6Zilber School of Public Health, University of Wisconsin at Milwaukee, Milwaukee, WI

    Background/Purpose: Our center previously reported increased carotid intima media thickness, and lower high-density lipoprotein (HDL) levels in young or middle-age adults with a history of…
  • Abstract Number: 1080 • 2013 ACR/ARHP Annual Meeting

    Incidence Of Coronary Heart Disease Associated With Arthritis: A Canadian Population-Based Cohort Study

    Orit Schieir1, S. Hogg-Johnson2, Richard H Glazier3 and Elizabeth M. Badley4, 1Epidemiology, University of Toronto, Toronto, ON, Canada, 2Institute for Work and Health, Toronto, ON, Canada, 3nstitute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, 4Division of Health Care and Outcomes Research, Toronto Western Research Institute; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Several individual types of arthritis have been associated with increased coronary heart disease (CHD) morbidity in clinical studies, but whether arthritis overall increases the…
  • Abstract Number: 757 • 2013 ACR/ARHP Annual Meeting

    Impact Of Cardiac Magnetic Resonance Imaging On Eosinophilic Granulomatosis With Polyangiitis Outcomes: A Long-Term Retrospective Study On 42 Patients

    Bertrand Dunogué1, Pascal Cohen2, Benjamin Terrier3, Julien Marmursztejn4, Denis Duboc4, Olivier Vignaux5 and Loic Guillevin3, 1Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 2National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 3Internal Medicine, Cochin University Hospital, Paris, France, 4Cardiology, Cochin University Hospital, Paris, France, 5Radiology, Cochin University Hospital, Paris, France

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) cardiomyopathy carries a poor prognosis, and is the main cause of 1st-year and long-term mortality. Morbidity due to chronic…
  • Abstract Number: 739 • 2013 ACR/ARHP Annual Meeting

    Cardiac Involvement In Granulomatosis With Polyangiitis

    Lucy McGeoch1, Simon Carette2, David Cuthberston3, Gary S. Hoffman4, Nader A. Khalidi5, Curry L Koening6, Carol A. Langford7, Paul A. Monach8, Larry W. Moreland9, Philip Seo10, Ulrich Specks11, Steven R. Ytterberg12, Carol McAlear13, Peter A Merkel14, Christian Pagnoux2 and The Vcrc15, 1Vasculitis clinic, Division of rheumatology, Mount Sinai Hospital, University Health Network, University of Toronto, Toronto, ON, Canada, 2Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 3Biostatistics, University of South Florida, Tampa, FL, 4Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 5Internal Medicine/Rheumatology, McMaster University, Hamilton, ON, Canada, 6Division of rheumatology, George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City and University of Utah, University of Utah School of Medicine, Salt Lake City, UT, 7Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, 8Rheumatology, Boston University, Boston, MA, 9Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 10Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, 11Mayo Clinic, Rochester, MN, 12Rheumatology Division, Mayo Clinic, Rochester, MN, 13University of Pennsylvania, Philadelphia, PA, 14Division of Rheumatology, University of Pennsylvania and VA Medical Center, Philadelphia, PA, 15University of Pennsylvania and VA Medical Center, Philadelphia, PA

    Background/Purpose: Prior cohort studies in Europe have found cardiac involvement to be rare in granulomatosis with polyangiitis (GPA) but associated with significant increases in mortality…
  • Abstract Number: 701 • 2013 ACR/ARHP Annual Meeting

    Extension Of Cardiac Damage Through The Delayed Enhancement Of Cardiac Magnetic Resonance: Predictive Value Of a Combined Approach Based On Clinical and Laboratory Findings, EKG-Holter and Cardiac Magnetic Resonance

    Silvia Laura Bosello1, Giacomo De Luca1, Agostino Meduri2, Giorgia Berardi1, Manuela Rucco1, Giovanni Canestrari1, Federico Parisi1 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy, 2INSTITUTE OF RADIOLOGY - Catholic University of the Sacred Heart, ROME, Italy

    Background/Purpose: Cardiac involvement is a relevant prognostic determinant in Systemic Sclerosis (SSc), but the diagnosis is often delayed due to the lack of a specific…
  • Abstract Number: 1458 • 2012 ACR/ARHP Annual Meeting

    Left Ventricular Diastolic Dysfunction May Play a Role in Pathophysiology and Poor Prognosis of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

    Sumiaki Tanaka1, Eisuke Ogawa1, Tatsuhiko Wada1, Tatsuo Nagai1, Jun Okada2 and Shunsei Hirohata1, 1Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan, 2Nutritional management, Kitasato Junior Collage of health and Hygienic Sciences, Minami-Uonuma, Japan

    Background/Purpose: Cardio-pulmonary involvements of systemic sclerosis (SSc), including cardiomyopathy, interstitial lung disease, and pulmonary arterial hypertension (PAH) are leading causes of SSc-related deaths.  Several potent…
  • Abstract Number: 290 • 2012 ACR/ARHP Annual Meeting

    Long-Term Outcomes in Neonatal Lupus

    Amit Saxena1, Peter M. Izmirly2, Deborah Friedman3 and Jill P. Buyon4, 1Medicine, New York University School of Medicine, New York, NY, 2Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 3Division of Pediatric Cardiology, New York Medical College, Valhalla, NY, 4Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: Several studies have evaluated mortality and short-term morbidity in neonatal lupus (NL), however there have been no substantive descriptions of the long term cardiac,…
  • Abstract Number: 70 • 2012 ACR/ARHP Annual Meeting

    The Impact of Systemic Autoimmune Rheumatic Disease On One-Year Mortality in Congestive Heart Failure Patients: A Population-Level Analysis

    Stephanie O. Keeling1, Asvina Bissonauth1, Becky Leung2 and Padmaja Kaul2, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Cardiology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Little is known about the prevalence of systemic autoimmune rheumatic diseases (SARDs) in patients with congestive heart failure (CHF) and its contribution to long-term…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology